Rheumatoid arthritis: vizsgálatok itt: Olaszország
20 of 25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Where
- Reggio Emilia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07137598 - 1/2. fázisTaking peopleA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Where
- Rome, Rozzano
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07412704 · EU 2025-520666-22-00 - 2. fázisTaking peopleAn Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- Where
- Padova, Reggio Emilia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07620392 · EU 2025-523579-47-00 - No phaseNot yet taking people in OlaszországAdded Value of HR-pQCT in Detecting Calcium Deposits in Rheumatoid Arthritis
- Where
- Bologna, Verona
- Életkor
- 60 év and over
- People
- 140
- Run by
- Istituto Ortopedico Rizzoli
See details and how to joinNCT07941089 - 1. fázisTaking peopleA Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)
- Where
- Rome, Rozzano
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Cullinan Therapeutics Inc.
See details and how to join2024-519114-31-00 - No phaseCsak meghívásosG7 Dual Mobility With Vivacit-E or Longevity PMCF
- Where
- Milan
- Életkor
- 18 év to 80 év
- People
- 358 worldwide
- Run by
- Zimmer Biomet
See details and how to joinNCT05548972 - No phaseTaking peopleUltrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach
- Where
- Bruneck
- Életkor
- 18 év to 84 év
- People
- 158
- Run by
- Italian Society for Rheumatology
See details and how to joinNCT05717179 - 1. fázisTaking peopleA Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
- Where
- Rome, Rozzano
- Életkor
- 18 év to 75 év
- People
- 21 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00 - 1. fázisTaking peopleA Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
- Where
- Rome, Rozzano
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- Cullinan Therapeutics Inc.
See details and how to joinNCT06994143 - 1. fázisTaking peopleA Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
- Where
- Reggio Emilia, Verona
- Életkor
- 18 év to 80 év
- People
- 54
- Run by
- Philogen S.p.A.
See details and how to joinNCT07245992 · EU 2024-517896-19-00 - 2. fázisTaking peopleA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Where
- Milan, Rozzano, Turin
- Életkor
- 18 év to 75 év
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06570798 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
- Where
- Padova, Reggio Emilia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 89 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2025-521034-28-00 - 4. fázisTaking people3TR-PARTNER-RA
- Where
- Monserrato, Novara, Padova, Rozzano
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2024-511470-79-00 - 1. fázisTaking peopleA Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
- Where
- Ferrara, Pavia, Reggio Emilia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 19 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-523127-21-00 - 4. fázisTaking peopleThe 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
- Where
- Milan, Monserrato, Padova, Rome, Rozzano, A.O.U Maggiore della Carità
- Életkor
- 18 év and over
- People
- 197 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2022-502021-18-00 - 2. fázisBefejeződöttAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Brescia, Milan, Rome
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - No phaseTaking peopleClinical Outcomes Study of the Nexel Total Elbow
- Where
- Torino
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Zimmer Biomet
See details and how to joinNCT02469662 - No phaseNot yet taking people in OlaszországIntra-Articular Adelmidrol 2%/Hyaluronic Acid 1% With or Without m/umPEA, in Knee Pain Due to Joint Degeneration.
- Where
- Verona
- Életkor
- 40 év and over
- People
- 80
- Run by
- Universita di Verona
See details and how to joinNCT07680101 - 1. fázisTaking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Ferrara, Rozzano
- Életkor
- 18 év to 70 év
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - 4. fázisTaking peopleMethMax trial
- Where
- Rozzano
- Életkor
- 18 év and over
- People
- 212 worldwide
- Run by
- Medical University of Vienna
See details and how to join2023-507714-27-00